Gapol, Jezra Roanne B.
HRN: 18-91-68 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2022
CEFUROXIME 750MG (VIAL)
06/30/2022
07/07/2022
IV
280mg
Q8Hrs
PCAP-C
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes